{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:09:44Z","timestamp":1793974184598,"version":"4.8.0"},"reference-count":344,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41582-024-00991-7","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T10:02:28Z","timestamp":1720087348000},"page":"475-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Brain\u2013body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"20","author":[{"given":"Sarah M.","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-1711","authenticated-orcid":false,"given":"Keith A.","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-8617","authenticated-orcid":false,"given":"Minh Dang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"991_CR1","unstructured":"Gorelick, P. B. & Alter, M. (eds.) Handbook of Neuroepidemiology (Marcel Dekker, 1994).\u00a0"},{"key":"991_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.47.2.571","volume":"47","author":"V McGuire","year":"1996","unstructured":"McGuire, V., Longstreth, W. T., Koepsell, T. D. & van Belle, G. Incidence of amyotrophic lateral sclerosis in three counties in Western Washington state. Neurology 47, 571\u2013573 (1996).","journal-title":"Neurology"},{"key":"991_CR3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000108917","volume":"29","author":"K Abhinav","year":"2007","unstructured":"Abhinav, K. et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. Neuroepidemiology 29, 44\u201348 (2007).","journal-title":"Neuroepidemiology"},{"key":"991_CR4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/01.wnl.0000343008.26874.d1","volume":"72","author":"A Chio","year":"2009","unstructured":"Chio, A. et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 72, 725\u2013731 (2009).","journal-title":"Neurology"},{"key":"991_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000120023","volume":"30","author":"MC V\u00e1zquez","year":"2008","unstructured":"V\u00e1zquez, M. C. et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 30, 105\u2013111 (2008).","journal-title":"Neuroepidemiology"},{"key":"991_CR6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.15585\/mmwr.mm6746a1","volume":"67","author":"P Mehta","year":"2018","unstructured":"Mehta, P. et al. Prevalence of amyotrophic lateral sclerosis \u2014 United States, 2015. MMWR Morb. Mortal. Wkly. Rep. 67, 1285\u20131289 (2018).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"991_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/WNL.52.3.504","volume":"52","author":"BJ Traynor","year":"1999","unstructured":"Traynor, B. J. et al. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 52, 504 (1999).","journal-title":"Neurology"},{"key":"991_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2008.09.024","volume":"276","author":"N Atsuta","year":"2009","unstructured":"Atsuta, N. et al. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 276, 163\u2013169 (2009).","journal-title":"J. Neurol. Sci."},{"key":"991_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2008.04.034","volume":"272","author":"A Nalini","year":"2008","unstructured":"Nalini, A., Thennarasu, K., Gourie-Devi, M., Shenoy, S. & Kulshreshtha, D. Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J. Neurol. Sci. 272, 60\u201370 (2008).","journal-title":"J. Neurol. Sci."},{"key":"991_CR10","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori, P. & Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 27, 1918\u20131929 (2020).","journal-title":"Eur. J. Neurol."},{"key":"991_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2010.03.028","volume":"294","author":"MR Turner","year":"2010","unstructured":"Turner, M. R. et al. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J. Neurol. Sci. 294, 81\u201385 (2010).","journal-title":"J. Neurol. Sci."},{"key":"991_CR12","volume":"21","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Chen, L., Tian, J. & Fan, D. Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis. BMC Neurol. 21, 405 (2021).","journal-title":"BMC Neurol."},{"key":"991_CR13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"991_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong, M. J. et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph. Lateral Scler. Front. Degener. 18, 153\u2013174 (2017).","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"991_CR15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","volume":"82","author":"A Chio","year":"2011","unstructured":"Chio, A., Calvo, A., Moglia, C., Mazzini, L. & Mora, G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J. Neurol. Neurosurg. Psychiatry 82, 740\u2013746 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR16","doi-asserted-by":"crossref","unstructured":"Eisen, A. & Krieger, C. Amyotrophic Lateral Sclerosis: a Synthesis of Research and Clinical Practice\u00a0(Cambridge Univ. Press, 1998).","DOI":"10.1017\/CBO9780511663307"},{"key":"991_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","volume":"7","author":"PA McCombe","year":"2010","unstructured":"McCombe, P. A. & Henderson, R. D. Effects of gender in amyotrophic lateral sclerosis. Gend. Med. 7, 557\u2013570 (2010).","journal-title":"Gend. Med."},{"key":"991_CR18","first-page":"47","volume":"25","author":"C Vlassoff","year":"2007","unstructured":"Vlassoff, C. Gender differences in determinants and consequences of health and illness. J. Health Popul. Nutr. 25, 47\u201361 (2007).","journal-title":"J. Health Popul. Nutr."},{"key":"991_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"991_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neurol.2019.09.008","volume":"176","author":"JA Pape","year":"2020","unstructured":"Pape, J. A. & Grose, J. H. The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. 176, 301\u2013315 (2020).","journal-title":"Rev. Neurol."},{"key":"991_CR21","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/ijms21103647","volume":"21","author":"F Trojsi","year":"2020","unstructured":"Trojsi, F., D\u2019Alvano, G., Bonavita, S. & Tedeschi, G. Genetics and sex in the pathogenesis of amyotrophic lateral sclerosis (ALS): is there a link? Int. J. Mol. Sci. 21, 3647 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"991_CR22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/21678421.2021.2023190","volume":"23","author":"P Mehta","year":"2022","unstructured":"Mehta, P. et al. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016. Amyotroph. Lateral Scler. Frontotemporal Degener. 23, 378\u2013382 (2022).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"991_CR23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2018-318974","volume":"90","author":"KY Jun","year":"2019","unstructured":"Jun, K. Y. et al. Epidemiology of ALS in Korea using nationwide big data. J. Neurol. Neurosurg. Psychiatry 90, 395\u2013403 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/jnnp-2015-312751","volume":"87","author":"N Shahrizaila","year":"2016","unstructured":"Shahrizaila, N. et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J. Neurol. Neurosurg. Psychiatry 87, 821\u2013830 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/17482961003610853","volume":"11","author":"ZR Manjaly","year":"2010","unstructured":"Manjaly, Z. R. et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph. Lateral Scler. 11, 439\u2013442 (2010).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/17482960902721626","volume":"10","author":"B Marin","year":"2009","unstructured":"Marin, B., Gil, J., Preux, P. M., Funalot, B. & Couratier, P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997\u20132007. Amyotroph. Lateral Scler. 10, 216\u2013220 (2009).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR27","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","volume":"101","author":"C Wolfson","year":"2023","unstructured":"Wolfson, C., Gauvin, D. E., Ishola, F. & Oskoui, M. Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review. Neurology 101, e613\u2013e623 (2023).","journal-title":"Neurology"},{"key":"991_CR28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000516752","volume":"55","author":"CA Brown","year":"2021","unstructured":"Brown, C. A., Lally, C., Kupelian, V. & Flanders, W. D. Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants. Neuroepidemiology 55, 342\u2013353 (2021).","journal-title":"Neuroepidemiology"},{"key":"991_CR29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jamaneurol.2017.1387","volume":"74","author":"A Chi\u00f2","year":"2017","unstructured":"Chi\u00f2, A. et al. Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d\u2019Aosta Register. JAMA Neurol. 74, 1097\u20131104 (2017).","journal-title":"JAMA Neurol."},{"key":"991_CR30","doi-asserted-by":"crossref","first-page":"152504","DOI":"10.1016\/j.scitotenv.2021.152504","volume":"817","author":"ME Newell","year":"2022","unstructured":"Newell, M. E., Adhikari, S. & Halden, R. U. Systematic and state-of the science review of the role of environmental factors in amyotrophic lateral sclerosis (ALS) or Lou Gehrig\u2019s disease. Sci. Total Environ. 817, 152504 (2022).","journal-title":"Sci. Total Environ."},{"key":"991_CR31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/mus.27085","volume":"63","author":"AS Andrew","year":"2021","unstructured":"Andrew, A. S. et al. Risk factors for amyotrophic lateral sclerosis: a regional United States case-control study. Muscle Nerve 63, 52\u201359 (2021).","journal-title":"Muscle Nerve"},{"key":"991_CR32","doi-asserted-by":"crossref","first-page":"122899","DOI":"10.1016\/j.jns.2024.122899","volume":"457","author":"SA Goutman","year":"2024","unstructured":"Goutman, S. A. et al. Avocational exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study. J. Neurol. Sci. 457, 122899 (2024).","journal-title":"J. Neurol. Sci."},{"key":"991_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/21678421.2017.1386688","volume":"19","author":"R Walhout","year":"2018","unstructured":"Walhout, R., Verstraete, E., van den Heuvel, M. P., Veldink, J. H. & van den Berg, L. H. Patterns of symptom development in patients with motor neuron disease. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 21\u201328 (2018).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"991_CR34","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"991_CR35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen, B. & Robberecht, W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 10, 661\u2013670 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"991_CR36","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.4103\/0366-6999.211538","volume":"130","author":"HG Zhang","year":"2017","unstructured":"Zhang, H. G., Chen, L., Tang, L., Zhang, N. & Fan, D. S. Clinical features of isolated bulbar palsy of amyotrophic lateral sclerosis in Chinese population. Chin. Med. J. 130, 1768\u20131772 (2017).","journal-title":"Chin. Med. J."},{"key":"991_CR37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/17482968.2011.551940","volume":"12","author":"JR Burrell","year":"2011","unstructured":"Burrell, J. R., Vucic, S. & Kiernan, M. C. Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 12, 283\u2013289 (2011).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000516344","volume":"55","author":"J Raymond","year":"2021","unstructured":"Raymond, J., Mehta, P., Larson, T., Pioro, E. P. & Horton, D. K. Reproductive history and age of onset for women diagnosed with amyotrophic lateral sclerosis: data from the National ALS Registry: 2010\u20132018. Neuroepidemiology 55, 416\u2013424 (2021).","journal-title":"Neuroepidemiology"},{"key":"991_CR39","doi-asserted-by":"publisher","unstructured":"Grassano, M. et al. Sex differences in amyotrophic lateral sclerosis survival and progression: a multidimensional analysis. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.26933 (2024).","DOI":"10.1002\/ana.26933"},{"key":"991_CR40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/21678421.2022.2067777","volume":"24","author":"S Pinto","year":"2023","unstructured":"Pinto, S., Gromicho, M., Oliveira Santos, M. O., Swash, M. & De Carvalho, M. Respiratory onset in amyotrophic lateral sclerosis: clinical features and spreading pattern. Amyotroph. Lateral Scler. Frontotemporal Degener. 24, 40\u201344 (2023).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"991_CR41","doi-asserted-by":"crossref","first-page":"117257","DOI":"10.1016\/j.jns.2020.117257","volume":"420","author":"P Fayemendy","year":"2021","unstructured":"Fayemendy, P. et al. Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. J. Neurol. Sci. 420, 117257 (2021).","journal-title":"J. Neurol. Sci."},{"key":"991_CR42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","volume":"89","author":"FJ Steyn","year":"2018","unstructured":"Steyn, F. J. et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry 89, 1016\u20131023 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR43","doi-asserted-by":"crossref","first-page":"7821672","DOI":"10.1155\/2017\/7821672","volume":"2017","author":"A Ferri","year":"2017","unstructured":"Ferri, A. & Coccurello, R. What is \u2018hyper\u2019 in the ALS hypermetabolism? Mediators Inflamm. 2017, 7821672 (2017).","journal-title":"Mediators Inflamm."},{"key":"991_CR44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17482960802295192","volume":"10","author":"B Funalot","year":"2009","unstructured":"Funalot, B., Desport, J. C., Sturtz, F., Camu, W. & Couratier, P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10, 113\u2013117 (2009).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13311-014-0332-8","volume":"12","author":"J Rosenfeld","year":"2015","unstructured":"Rosenfeld, J. & Strong, M. J. Challenges in the understanding and treatment of amyotrophic lateral sclerosis\/motor neuron disease. Neurotherapeutics 12, 317\u2013325 (2015).","journal-title":"Neurotherapeutics"},{"key":"991_CR46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"991_CR47","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1073\/pnas.95.11.6361","volume":"95","author":"LB Corson","year":"1998","unstructured":"Corson, L. B., Strain, J. J., Culotta, V. C. & Cleveland, D. W. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl Acad. Sci. USA 95, 6361\u20136366 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR48","doi-asserted-by":"crossref","first-page":"661447","DOI":"10.3389\/fncel.2021.661447","volume":"15","author":"J Smeyers","year":"2021","unstructured":"Smeyers, J., Banchi, E. G. & Latouche, M. C9ORF72: what it is, what it does, and why it matters. Front. Cell. Neurosci. 15, 661447 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"991_CR49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra, R. & Isaacs, A. M. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14, 544\u2013558 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"991_CR50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk, T. R. & Rousseaux, M. W. C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 15, 45 (2020).","journal-title":"Mol. Neurodegener."},{"key":"991_CR51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A. & Patel, B. K. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 12, 25 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"991_CR52","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1212\/WNL.0b013e3182735d36","volume":"79","author":"A Chio","year":"2012","unstructured":"Chio, A. et al. Extensive genetics of ALS: a population-based study in Italy. Neurology 79, 1983\u20131989 (2012).","journal-title":"Neurology"},{"key":"991_CR53","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/awab472","volume":"145","author":"K Salmon","year":"2022","unstructured":"Salmon, K. et al. The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis. Brain 145, 1207\u20131210 (2022).","journal-title":"Brain"},{"key":"991_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03891-8","volume":"12","author":"M Berdy\u0144ski","year":"2022","unstructured":"Berdy\u0144ski, M. et al. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci. Rep. 12, 103 (2022).","journal-title":"Sci. Rep."},{"key":"991_CR55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1073858414561795","volume":"21","author":"RKA Bunton-Stasyshyn","year":"2015","unstructured":"Bunton-Stasyshyn, R. K. A., Saccon, R. A., Fratta, P. & Fisher, E. M. C. SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes. Neuroscientist 21, 519\u2013529 (2015).","journal-title":"Neuroscientist"},{"key":"991_CR56","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/brain\/awt097","volume":"136","author":"RA Saccon","year":"2013","unstructured":"Saccon, R. A., Bunton-Stasyshyn, R. K. A., Fisher, E. M. C. & Fratta, P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136, 2342\u20132358 (2013).","journal-title":"Brain"},{"key":"991_CR57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","volume":"108","author":"G Kim","year":"2020","unstructured":"Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R. & Gitler, A. D. ALS genetics: gains, losses, and implications for future therapies. Neuron 108, 822\u2013842 (2020).","journal-title":"Neuron"},{"key":"991_CR58","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.93.12.5709","volume":"93","author":"MB Yim","year":"1996","unstructured":"Yim, M. B. et al. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl Acad. Sci. USA 93, 5709\u20135714 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245\u2013256 (2011).","journal-title":"Neuron"},{"key":"991_CR60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268 (2011).","journal-title":"Neuron"},{"key":"991_CR61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/WCO.0b013e32835a3efb","volume":"25","author":"M van Blitterswijk","year":"2012","unstructured":"van Blitterswijk, M., DeJesus-Hernandez, M. & Rademakers, R. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia. Curr. Opin. Neurol. 25, 689\u2013700 (2012).","journal-title":"Curr. Opin. Neurol."},{"key":"991_CR62","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1212\/WNL.0000000000004494","volume":"89","author":"AF Curtis","year":"2017","unstructured":"Curtis, A. F. et al. Sex differences in the prevalence of genetic mutations in FTD and ALS. Neurology 89, 1633\u20131642 (2017).","journal-title":"Neurology"},{"key":"991_CR63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fnins.2020.00316","volume":"14","author":"F Esselin","year":"2020","unstructured":"Esselin, F. et al. Clinical phenotype and inheritance in patients with C9ORF72 hexanucleotide repeat expansion: results from a large French cohort. Front. Neurosci. 14, 316 (2020).","journal-title":"Front. Neurosci."},{"key":"991_CR64","doi-asserted-by":"crossref","first-page":"fcad087","DOI":"10.1093\/braincomms\/fcad087","volume":"5","author":"M Wiesenfarth","year":"2023","unstructured":"Wiesenfarth, M. et al. Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations. Brain Commun. 5, fcad087 (2023).","journal-title":"Brain Commun."},{"key":"991_CR65","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000665","volume":"8","author":"H Laaksovirta","year":"2022","unstructured":"Laaksovirta, H. et al. ALS in Finland: major genetic variants and clinical characteristics of patients with and without the C9orf72 hexanucleotide repeat expansion. Neurol. Genet. 8, e665 (2022).","journal-title":"Neurol. Genet."},{"key":"991_CR66","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.18632\/aging.202251","volume":"12","author":"I Yusipov","year":"2020","unstructured":"Yusipov, I. et al. Age-related DNA methylation changes are sex-specific: a comprehensive assessment. Aging 12, 24057\u201324080 (2020).","journal-title":"Aging"},{"key":"991_CR67","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/hmg\/9.18.2767","volume":"9","author":"IV Kovtun","year":"2000","unstructured":"Kovtun, I. V., Therneau, T. M. & McMurray, C. T. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington\u2019s disease gene. Hum. Mol. Genet. 9, 2767\u20132775 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"991_CR68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fnins.2019.00485","volume":"13","author":"F Trojsi","year":"2019","unstructured":"Trojsi, F. et al. Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: the effect of male sex on survival of C9orf72 positive patients. Front. Neurosci. 13, 485 (2019).","journal-title":"Front. Neurosci."},{"key":"991_CR69","first-page":"281","volume":"88","author":"J Rooney","year":"2017","unstructured":"Rooney, J. et al. C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 88, 281 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR70","volume":"7","author":"NA Murphy","year":"2017","unstructured":"Murphy, N. A. et al. Age-related penetrance of the C9orf72 repeat expansion. Sci. Rep. 7, 2116 (2017).","journal-title":"Sci. Rep."},{"key":"991_CR71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry, A. et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582, 89\u201394 (2020).","journal-title":"Nature"},{"key":"991_CR72","doi-asserted-by":"crossref","first-page":"347ra93","DOI":"10.1126\/scitranslmed.aaf6038","volume":"8","author":"A Burberry","year":"2016","unstructured":"Burberry, A. et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 8, 347ra93 (2016).","journal-title":"Sci. Transl. Med."},{"key":"991_CR73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006443","volume":"12","author":"J Ugolino","year":"2016","unstructured":"Ugolino, J. et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 12, e1006443 (2016).","journal-title":"PLoS Genet."},{"key":"991_CR74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.24453","volume":"78","author":"M Koppers","year":"2015","unstructured":"Koppers, M. et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol. 78, 426\u2013438 (2015).","journal-title":"Ann. Neurol."},{"key":"991_CR75","doi-asserted-by":"crossref","first-page":"eabb3774","DOI":"10.1126\/scitranslmed.abb3774","volume":"12","author":"CN Cook","year":"2020","unstructured":"Cook, C. N. et al. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med. 12, eabb3774 (2020).","journal-title":"Sci. Transl. Med."},{"key":"991_CR76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-09593-z","volume":"12","author":"BM Verdone","year":"2022","unstructured":"Verdone, B. M. et al. A mouse model with widespread expression of the C9orf72-linked glycine\u2013arginine dipeptide displays non-lethal ALS\/FTD-like phenotypes. Sci. Rep. 12, 5644 (2022).","journal-title":"Sci. Rep."},{"key":"991_CR77","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","volume":"90","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS\/FTD. Neuron 90, 521\u2013534 (2016).","journal-title":"Neuron"},{"key":"991_CR78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","volume":"18","author":"JL Podcasy","year":"2016","unstructured":"Podcasy, J. L. & Epperson, C. N. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin. Neurosci. 18, 437\u2013446 (2016).","journal-title":"Dialogues Clin. Neurosci."},{"key":"991_CR79","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1007\/s10072-022-06185-7","volume":"43","author":"M Pengo","year":"2022","unstructured":"Pengo, M. et al. Sex influences clinical phenotype in frontotemporal dementia. Neurol. Sci. 43, 5281\u20135287 (2022).","journal-title":"Neurol. Sci."},{"key":"991_CR80","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/hmg\/ddr021","volume":"20","author":"KK McDonald","year":"2011","unstructured":"McDonald, K. K. et al. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 20, 1400\u20131410 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"991_CR81","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/emboj\/20.7.1774","volume":"20","author":"E Buratti","year":"2001","unstructured":"Buratti, E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774\u20131784 (2001).","journal-title":"EMBO J."},{"key":"991_CR82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000444788","volume":"6","author":"A Junttila","year":"2016","unstructured":"Junttila, A. et al. Cerebrospinal fluid TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis patients with and without the C9ORF72 hexanucleotide expansion. Dement. Geriatr. Cogn. Dis. Extra 6, 142\u2013149 (2016).","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"991_CR83","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3390\/genes14112039","volume":"14","author":"M Lombardi","year":"2023","unstructured":"Lombardi, M. et al. Variability in clinical phenotype in TARDBP mutations: amyotrophic lateral sclerosis case description and literature review. Genes 14, 2309 (2023).","journal-title":"Genes"},{"key":"991_CR84","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. & Baloh, R. H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 106, 18809\u201318814 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR85","volume":"10","author":"J Watkins","year":"2020","unstructured":"Watkins, J. et al. Female sex mitigates motor and behavioural phenotypes in TDP-43Q331K knock-in mice. Sci. Rep. 10, 19220 (2020).","journal-title":"Sci. Rep."},{"key":"991_CR86","doi-asserted-by":"crossref","first-page":"839526","DOI":"10.3389\/fcimb.2022.839526","volume":"12","author":"S Martin","year":"2022","unstructured":"Martin, S., Battistini, C. & Sun, J. A gut feeling in amyotrophic lateral sclerosis: microbiome of mice and men. Front. Cell. Infect. Microbiol. 12, 839526 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"991_CR87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2012.04.003","volume":"1460","author":"Y Guo","year":"2012","unstructured":"Guo, Y. et al. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 1460, 88\u201395 (2012).","journal-title":"Brain Res."},{"key":"991_CR88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/iep.12006","volume":"94","author":"MA Esmaeili","year":"2013","unstructured":"Esmaeili, M. A., Panahi, M., Yadav, S., Hennings, L. & Kiaei, M. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int. J. Exp. Pathol. 94, 56\u201364 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"991_CR89","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1242\/dmm.024786","volume":"9","author":"KS Coughlan","year":"2016","unstructured":"Coughlan, K. S., Halang, L., Woods, I. & Prehn, J. H. M. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6\/J mice. Dis. Model. Mech. 9, 1029\u20131037 (2016).","journal-title":"Dis. Model. Mech."},{"key":"991_CR90","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.clinbiochem.2008.08.064","volume":"41","author":"O Khymenets","year":"2008","unstructured":"Khymenets, O. et al. Role of sex and time of blood sampling in SOD1 and SOD2 expression variability. Clin. Biochem. 41, 1348\u20131354 (2008).","journal-title":"Clin. Biochem."},{"key":"991_CR91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-018-0142-8","volume":"8","author":"L Tang","year":"2019","unstructured":"Tang, L., Ma, Y., Liu, X., Chen, L. & Fan, D. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl. Neurodegener. 8, 2 (2019).","journal-title":"Transl. Neurodegener."},{"key":"991_CR92","first-page":"e802","volume":"94","author":"A Chi\u00f2","year":"2020","unstructured":"Chi\u00f2, A. et al. ALS phenotype is influenced by age, sex, and genetics. Neurology 94, e802\u2013e810 (2020).","journal-title":"Neurology"},{"key":"991_CR93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tox.2013.04.004","volume":"311","author":"C Cervetto","year":"2013","unstructured":"Cervetto, C., Frattaroli, D., Maura, G. & Marcoli, M. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism. Toxicology 311, 69\u201377 (2013).","journal-title":"Toxicology"},{"key":"991_CR94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/17482960600982447","volume":"8","author":"M Suzuki","year":"2007","unstructured":"Suzuki, M. et al. Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph. Lateral Scler. 8, 20\u201325 (2007).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1538\/expanim.14-0077","volume":"64","author":"S Oliv\u00e1n","year":"2015","unstructured":"Oliv\u00e1n, S. et al. Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp. Anim. 64, 147\u2013153 (2015).","journal-title":"Exp. Anim."},{"key":"991_CR96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-140068","volume":"2","author":"SR Pfohl","year":"2015","unstructured":"Pfohl, S. R., Halicek, M. T. & Mitchell, C. S. Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis. J. Neuromuscul. Dis. 2, 137\u2013150 (2015).","journal-title":"J. Neuromuscul. Dis."},{"key":"991_CR97","first-page":"4771","volume":"25","author":"Y Ohta","year":"2016","unstructured":"Ohta, Y. et al. Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. Hum. Mol. Genet. 25, 4771\u20134786 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"991_CR98","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1460-9568.2008.06374.x","volume":"28","author":"NC Stam","year":"2008","unstructured":"Stam, N. C. et al. Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 28, 717\u2013723 (2008).","journal-title":"Eur. J. Neurosci."},{"key":"991_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","volume":"236","author":"TD Heiman-Patterson","year":"2005","unstructured":"Heiman-Patterson, T. D. et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci. 236, 1\u20137 (2005).","journal-title":"J. Neurol. Sci."},{"key":"991_CR100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nn1603","volume":"9","author":"M Urushitani","year":"2006","unstructured":"Urushitani, M. et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108\u2013118 (2006).","journal-title":"Nat. Neurosci."},{"key":"991_CR101","doi-asserted-by":"crossref","first-page":"21777","DOI":"10.1073\/pnas.0902174106","volume":"106","author":"F Gros-Louis","year":"2009","unstructured":"Gros-Louis, F. et al. Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 106, 21777\u201321782 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","volume":"477","author":"H-X Deng","year":"2011","unstructured":"Deng, H.-X. et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia. Nature 477, 211\u2013215 (2011).","journal-title":"Nature"},{"key":"991_CR103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40478-019-0758-7","volume":"7","author":"L Renaud","year":"2019","unstructured":"Renaud, L., Picher-Martel, V., Codron, P. & Julien, J. P. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. Commun. 7, 103 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"991_CR104","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/15548627.2021.1926656","volume":"18","author":"JP Chua","year":"2022","unstructured":"Chua, J. P., De Calbiac, H., Kabashi, E. & Barmada, S. J. Autophagy and ALS: mechanistic insights and therapeutic implications. Autophagy 18, 254\u2013282 (2022).","journal-title":"Autophagy"},{"key":"991_CR105","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1111\/febs.16129","volume":"289","author":"BC Lin","year":"2022","unstructured":"Lin, B. C., Higgins, N. R., Phung, T. H. & Monteiro, M. J. UBQLN proteins in health and disease with a focus on UBQLN2 in ALS\/FTD. FEBS J. 289, 6132\u20136153 (2022).","journal-title":"FEBS J."},{"key":"991_CR106","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.str.2019.05.006","volume":"27","author":"N Higgins","year":"2019","unstructured":"Higgins, N., Lin, B. & Monteiro, M. J. Lou Gehrig\u2019s disease (ALS): UBQLN2 mutations strike out of phase. Structure 27, 879\u2013881 (2019).","journal-title":"Structure"},{"key":"991_CR107","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/21678421.2013.824001","volume":"14","author":"J Vengoechea","year":"2013","unstructured":"Vengoechea, J., David, M. P., Yaghi, S. R., Carpenter, L. & Rudnicki, S. A. Clinical variability and female penetrance in X-linked familial FTD\/ALS caused by a P506S mutation in UBQLN2. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 615\u2013619 (2013).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"991_CR108","doi-asserted-by":"crossref","first-page":"229.e5","DOI":"10.1016\/j.neurobiolaging.2018.08.015","volume":"73","author":"SA Gkazi","year":"2019","unstructured":"Gkazi, S. A. et al. Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia. Neurobiol. Aging 73, 229.e5\u2013229.e9 (2019).","journal-title":"Neurobiol. Aging"},{"key":"991_CR109","doi-asserted-by":"crossref","first-page":"E11485","DOI":"10.1073\/pnas.1811997115","volume":"115","author":"EJ Alexander","year":"2018","unstructured":"Alexander, E. J. et al. Ubiquilin 2 modulates ALS\/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proc. Natl Acad. Sci. USA 115, E11485\u2013E11494 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR110","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.molcel.2018.02.004","volume":"69","author":"TP Dao","year":"2018","unstructured":"Dao, T. P. et al. Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol. Cell 69, 965\u2013978.e6 (2018).","journal-title":"Mol. Cell"},{"key":"991_CR111","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/hmg\/ddv020","volume":"24","author":"KM Gilpin","year":"2015","unstructured":"Gilpin, K. M., Chang, L. & Monteiro, M. J. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum. Mol. Genet. 24, 2565\u20132577 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"991_CR112","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-015-0162-6","volume":"8","author":"V Picher-Martel","year":"2015","unstructured":"Picher-Martel, V., Dutta, K., Phaneuf, D., Sobue, G. & Julien, J. P. Ubiquilin-2 drives NF-\u03baB activity and cytosolic TDP-43 aggregation in neuronal cells. Mol. Brain 8, 71 (2015).","journal-title":"Mol. Brain"},{"key":"991_CR113","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1007\/s12035-018-1411-3","volume":"56","author":"V Picher-Martel","year":"2019","unstructured":"Picher-Martel, V., Renaud, L., Bareil, C. & Julien, J. P. Neuronal expression of UBQLN2P497H exacerbates TDP-43 pathology in TDP-43G348C mice through interaction with ubiquitin. Mol. Neurobiol. 56, 4680\u20134696 (2019).","journal-title":"Mol. Neurobiol."},{"key":"991_CR114","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143948","volume":"6","author":"AM Malik","year":"2021","unstructured":"Malik, A. M. & Barmada, S. J. Matrin 3 in neuromuscular disease: physiology and pathophysiology. JCI Insight 6, e143948 (2021).","journal-title":"JCI Insight"},{"key":"991_CR115","volume":"8","author":"MCG Iradi","year":"2018","unstructured":"Iradi, M. C. G. et al. Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Sci. Rep. 8, 4049 (2018).","journal-title":"Sci. Rep."},{"key":"991_CR116","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.3688","volume":"17","author":"JO Johnson","year":"2014","unstructured":"Johnson, J. O. et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664\u2013666 (2014).","journal-title":"Nat. Neurosci."},{"key":"991_CR117","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbapap.2013.03.020","volume":"1834","author":"JA Cassel","year":"2013","unstructured":"Cassel, J. A. & Reitz, A. B. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochim. Biophys. Acta 1834, 964\u2013971 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"991_CR118","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/WCO.0000000000000488","volume":"30","author":"MJ Strong","year":"2017","unstructured":"Strong, M. J. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr. Opin. Neurol. 30, 599\u2013607 (2017).","journal-title":"Curr. Opin. Neurol."},{"key":"991_CR119","doi-asserted-by":"crossref","first-page":"eaba3066","DOI":"10.1126\/science.aba3066","volume":"369","author":"M Oliva","year":"2020","unstructured":"Oliva, M. et al. The impact of sex on gene expression across human tissues. Science 369, eaba3066 (2020).","journal-title":"Science"},{"key":"991_CR120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neubiorev.2013.12.004","volume":"39","author":"ANV Ruigrok","year":"2014","unstructured":"Ruigrok, A. N. V. et al. A meta-analysis of sex differences in human brain structure. Neurosci. Biobehav. Rev. 39, 34\u201350 (2014).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"991_CR121","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/cercor\/bhz129","volume":"30","author":"S Weis","year":"2020","unstructured":"Weis, S. et al. Sex classification by resting state brain connectivity. Cereb. Cortex 30, 824\u2013835 (2020).","journal-title":"Cereb. Cortex"},{"key":"991_CR122","doi-asserted-by":"crossref","first-page":"1838682","DOI":"10.1155\/2022\/1838682","volume":"2022","author":"V Renga","year":"2022","unstructured":"Renga, V. Brain connectivity and network analysis in amyotrophic lateral sclerosis. Neurol. Res. Int. 2022, 1838682 (2022).","journal-title":"Neurol. Res. Int."},{"key":"991_CR123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/21678421.2013.865749","volume":"15","author":"P Bede","year":"2014","unstructured":"Bede, P., Elamin, M., Byrne, S. & Hardiman, O. Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph. Lateral Scler. Front. Degener. 15, 235\u2013243 (2014).","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"991_CR124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6","volume":"44","author":"A Pfefferbaum","year":"2000","unstructured":"Pfefferbaum, A. et al. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn. Reson. Med. 44, 259\u2013268 (2000).","journal-title":"Magn. Reson. Med."},{"key":"991_CR125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00702-021-02413-0","volume":"128","author":"F Trojsi","year":"2021","unstructured":"Trojsi, F. et al. Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS). J. Neural Transm. 128, 1881\u20131897 (2021).","journal-title":"J. Neural Transm."},{"key":"991_CR126","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.neuron.2023.01.010","volume":"111","author":"MJ Workman","year":"2023","unstructured":"Workman, M. J. et al. Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects. Neuron 111, 1191\u20131204.e5 (2023).","journal-title":"Neuron"},{"key":"991_CR127","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/biom14030289","volume":"14","author":"K Stoklund Dittlau","year":"2024","unstructured":"Stoklund Dittlau, K. & Freude, K. Astrocytes: the stars in neurodegeneration? Biomolecules 14, 289 (2024).","journal-title":"Biomolecules"},{"key":"991_CR128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-023-00665-w","volume":"18","author":"M Xie","year":"2023","unstructured":"Xie, M., Pallegar, P. N., Parusel, S., Nguyen, A. T. & Wu, L. J. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms. Mol. Neurodegener. 18, 75 (2023).","journal-title":"Mol. Neurodegener."},{"key":"991_CR129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251\u2013253 (2008).","journal-title":"Nat. Neurosci."},{"key":"991_CR130","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389\u20131392 (2006).","journal-title":"Science"},{"key":"991_CR131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement, A. M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113\u2013117 (2003).","journal-title":"Science"},{"key":"991_CR132","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0802556105","volume":"105","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka, K. et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl Acad. Sci. USA 105, 7594\u20137599 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR133","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1046\/j.1365-2826.2002.00858.x","volume":"14","author":"SK Amateau","year":"2002","unstructured":"Amateau, S. K. & McCarthy, M. M. Sexual differentiation of astrocyte morphology in the developing rat preoptic area. J. Neuroendocrinol. 14, 904\u2013910 (2002).","journal-title":"J. Neuroendocrinol."},{"key":"991_CR134","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yhbeh.2008.10.016","volume":"55","author":"C Arias","year":"2009","unstructured":"Arias, C. et al. Sex and estrous cycle-dependent differences in glial fibrillary acidic protein immunoreactivity in the adult rat hippocampus. Horm. Behav. 55, 257\u2013263 (2009).","journal-title":"Horm. Behav."},{"key":"991_CR135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0304-3940(94)11175-I","volume":"184","author":"P Collado","year":"1995","unstructured":"Collado, P., Beyer, C., Hutchison, J. B. & Holman, S. D. Hypothalamic distribution of astrocytes is gender-related in Mongolian gerbils. Neurosci. Lett. 184, 86\u201389 (1995).","journal-title":"Neurosci. Lett."},{"key":"991_CR136","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jnr.20372","volume":"79","author":"NM Conejo","year":"2005","unstructured":"Conejo, N. M. et al. Influence of gonadal steroids on the glial fibrillary acidic protein\u2010immunoreactive astrocyte population in young rat hippocampus. J. Neurosci. Res. 79, 488\u2013494 (2005).","journal-title":"J. Neurosci. Res."},{"key":"991_CR137","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0960-0760(95)00066-9","volume":"53","author":"LM Garcia-Segura","year":"1995","unstructured":"Garcia-Segura, L. M., Due\u00f1as, M., Busiguina, S., Naftolin, F. & Chowen, J. A. Gonadal hormone regulation of neuronal-glial interactions in the developing neuroendocrine hypothalamus. J. Steroid Biochem. Mol. Biol. 53, 293\u2013298 (1995).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"991_CR138","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-8993(88)90239-9","volume":"456","author":"LM Garcia-Segura","year":"1988","unstructured":"Garcia-Segura, L. M. et al. The distribution of glial fibrillary acidic protein in the adult rat brain is influenced by the neonatal levels of sex steroids. Brain Res. 456, 357\u2013363 (1988).","journal-title":"Brain Res."},{"key":"991_CR139","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1523\/JNEUROSCI.1158-10.2010","volume":"30","author":"J Kuo","year":"2010","unstructured":"Kuo, J., Hamid, N., Bondar, G., Prossnitz, E. R. & Micevych, P. Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J. Neurosci. 30, 12950\u201312957 (2010).","journal-title":"J. Neurosci."},{"key":"991_CR140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0361-9230(02)00758-X","volume":"58","author":"AA Rasia-Filho","year":"2002","unstructured":"Rasia-Filho, A. A., Xavier, L. L., dos Santos, P., Gehlen, G. & Achaval, M. Glial fibrillary acidic protein immunodetection and immunoreactivity in the anterior and posterior medial amygdala of male and female rats. Brain Res. Bull. 58, 67\u201375 (2002).","journal-title":"Brain Res. Bull."},{"key":"991_CR141","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/glia.440050103","volume":"5","author":"I Su\u00e1rez","year":"1992","unstructured":"Su\u00e1rez, I., Bodega, G., Rubio, M. & Fern\u00e1ndez, B. Sexual dimorphism in the hamster cerebellum demonstrated by glial fibrillary acidic protein (GFAP) and vimentin immunoreactivity. Glia 5, 10\u201316 (1992).","journal-title":"Glia"},{"key":"991_CR142","first-page":"79","volume":"178","author":"I Su\u00e1rez","year":"1991","unstructured":"Su\u00e1rez, I., Bodega, G., Rubio, M. & Fernandez, B. Sexual dimorphism in the distribution of glial fibrillary acidic protein in the supraoptic nucleus of the hamster. J. Anat. 178, 79\u201382 (1991).","journal-title":"J. Anat."},{"key":"991_CR143","doi-asserted-by":"crossref","first-page":"100989","DOI":"10.1016\/j.yfrne.2022.100989","volume":"65","author":"L Dion-Albert","year":"2022","unstructured":"Dion-Albert, L. et al. Sex differences in the blood\u2013brain barrier: implications for mental health. Front. Neuroendocrinol. 65, 100989 (2022).","journal-title":"Front. Neuroendocrinol."},{"key":"991_CR144","doi-asserted-by":"crossref","first-page":"011509","DOI":"10.1063\/5.0035610","volume":"5","author":"CM Weber","year":"2021","unstructured":"Weber, C. M. & Clyne, A. M. Sex differences in the blood\u2013brain barrier and neurodegenerative diseases. APL Bioeng. 5, 011509 (2021).","journal-title":"APL Bioeng."},{"key":"991_CR145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.jcbfm.9600331","volume":"27","author":"M Liu","year":"2007","unstructured":"Liu, M., Hurn, P. D., Roselli, C. E. & Alkayed, N. J. Role of P450 aromatase in sex-specific astrocytic cell death. J. Cereb. Blood Flow Metab. 27, 135\u2013141 (2007).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"991_CR146","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey, J. et al. Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat. Neurosci. 26, 150\u2013162 (2023).","journal-title":"Nat. Neurosci."},{"key":"991_CR147","doi-asserted-by":"crossref","first-page":"102782","DOI":"10.1016\/j.conb.2023.102782","volume":"83","author":"KA Nave","year":"2023","unstructured":"Nave, K. A., Asadollahi, E. & Sasmita, A. Expanding the function of oligodendrocytes to brain energy metabolism. Curr. Opin. Neurobiol. 83, 102782 (2023).","journal-title":"Curr. Opin. Neurobiol."},{"key":"991_CR148","doi-asserted-by":"crossref","first-page":"101866","DOI":"10.1016\/j.scr.2020.101866","volume":"46","author":"K Yasuda","year":"2020","unstructured":"Yasuda, K. et al. Sex-specific differences in transcriptomic profiles and cellular characteristics of oligodendrocyte precursor cells. Stem Cell Res. 46, 101866 (2020).","journal-title":"Stem Cell Res."},{"key":"991_CR149","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yfrne.2018.11.003","volume":"52","author":"A Villa","year":"2019","unstructured":"Villa, A., Della Torre, S. & Maggi, A. Sexual differentiation of microglia. Front. Neuroendocrinol. 52, 156\u2013164 (2019).","journal-title":"Front. Neuroendocrinol."},{"key":"991_CR150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.molmed.2019.05.001","volume":"25","author":"L Kodama","year":"2019","unstructured":"Kodama, L. & Gan, L. Do microglial sex differences contribute to sex differences in neurodegenerative diseases? Trends Mol. Med. 25, 741\u2013749 (2019).","journal-title":"Trends Mol. Med."},{"key":"991_CR151","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306.e6 (2019).","journal-title":"Cell Rep."},{"key":"991_CR152","doi-asserted-by":"publisher","unstructured":"Gomes, L. C. et al. Multiomic ALS signatures highlight sex differences and molecular subclusters and identify the MAPK pathway as therapeutic target. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.08.14.553180 (2023).","DOI":"10.1101\/2023.08.14.553180"},{"key":"991_CR153","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1469-7580.2002.00064.x","volume":"200","author":"NJ Abbott","year":"2002","unstructured":"Abbott, N. J. Astrocyte\u2013endothelial interactions and blood\u2013brain barrier permeability. J. Anat. 200, 629\u2013638 (2002).","journal-title":"J. Anat."},{"key":"991_CR154","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman, R. & Prat, A. The blood\u2013brain barrier. Cold Spring Harb. Perspect. Biol. 7, a020412 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"991_CR155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","volume":"33","author":"LL Muldoon","year":"2013","unstructured":"Muldoon, L. L. et al. Immunologic privilege in the central nervous system and the blood\u2013brain barrier. J. Cereb. Blood Flow Metab. 33, 13\u201321 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"991_CR156","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10790268.1995.11719399","volume":"18","author":"LD Prockop","year":"1995","unstructured":"Prockop, L. D., Naidu, K. A., Binard, J. E. & Ransohoff, J. Selective permeability of [3H]-D-mannitol and [14C]-carboxyl-inulin across the blood-brain barrier and blood-spinal cord barrier in the rabbit. J. Spinal Cord Med. 18, 221\u2013226 (1995).","journal-title":"J. Spinal Cord Med."},{"key":"991_CR157","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-5728(97)00034-9","volume":"76","author":"W Pan","year":"1997","unstructured":"Pan, W., Banks, W. A. & Kastin, A. J. Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76, 105\u2013111 (1997).","journal-title":"J. Neuroimmunol."},{"key":"991_CR158","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","volume":"111","author":"EA Winkler","year":"2014","unstructured":"Winkler, E. A. et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc. Natl Acad. Sci. USA 111, E1035\u2013E1042 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR159","volume":"12","author":"H Yoon","year":"2017","unstructured":"Yoon, H., Walters, G., Paulsen, A. R. & Scarisbrick, I. A. Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination. PLoS ONE 12, e0180697 (2017).","journal-title":"PLoS ONE"},{"key":"991_CR160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","volume":"1157","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis, S. et al. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 1157, 126\u2013137 (2007).","journal-title":"Brain Res."},{"key":"991_CR161","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nn2073","volume":"11","author":"Z Zhong","year":"2008","unstructured":"Zhong, Z. et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11, 420\u2013422 (2008).","journal-title":"Nat. Neurosci."},{"key":"991_CR162","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jnr.22594","volume":"89","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki, K. et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J. Neurosci. Res. 89, 718\u2013728 (2011).","journal-title":"J. Neurosci. Res."},{"key":"991_CR163","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0271678X231153281","volume":"43","author":"M Steinruecke","year":"2023","unstructured":"Steinruecke, M. et al. Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: proposed mechanisms and clinical implications. J. Cereb. Blood Flow Metab. 43, 642\u2013654 (2023).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"991_CR164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","volume":"1398","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis, S. et al. Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res. 1398, 113\u201325 (2011).","journal-title":"Brain Res."},{"key":"991_CR165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-5728(84)90042-0","volume":"6","author":"H Donnenfeld","year":"1984","unstructured":"Donnenfeld, H., Kascsak, R. J. & Bartfeld, H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 6, 51\u201357 (1984).","journal-title":"J. Neuroimmunol."},{"key":"991_CR166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel, J. S. et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221\u2013235 (2004).","journal-title":"Ann. Neurol."},{"key":"991_CR167","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/21678421.2015.1011663","volume":"16","author":"M Yamadera","year":"2015","unstructured":"Yamadera, M. et al. Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 393\u2013401 (2015).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"991_CR168","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","volume":"1469","author":"S Garbuzova-Davis","year":"2012","unstructured":"Garbuzova-Davis, S. et al. Impaired blood-brain\/spinal cord barrier in ALS patients. Brain Res. 1469, 114\u2013128 (2012).","journal-title":"Brain Res."},{"key":"991_CR169","doi-asserted-by":"crossref","first-page":"844916","DOI":"10.3389\/fnbeh.2022.844916","volume":"16","author":"C Dalla","year":"2022","unstructured":"Dalla, C., Pavlidi, P., Sakelliadou, D. G., Grammatikopoulou, T. & Kokras, N. Sex differences in blood\u2013brain barrier transport of psychotropic drugs. Front. Behav. Neurosci. 16, 844916 (2022).","journal-title":"Front. Behav. Neurosci."},{"key":"991_CR170","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.3390\/ijms241311196","volume":"24","author":"H Alarcan","year":"2023","unstructured":"Alarcan, H. et al. Implication of central nervous system barrier impairment in amyotrophic lateral sclerosis: gender-related difference in patients. Int. J. Mol. Sci. 24, 11196 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"991_CR171","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/gerona\/glz275","volume":"75","author":"MA Hakim","year":"2020","unstructured":"Hakim, M. A., Chum, P. P., Buchholz, J. N. & Behringer, E. J. Aging alters cerebrovascular endothelial GPCR and K+ channel function: divergent role of biological sex. J. Gerontol. A 75, 2064\u20132073 (2020).","journal-title":"J. Gerontol. A"},{"key":"991_CR172","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1161\/01.CIR.94.12.3341","volume":"94","author":"J Bauersachs","year":"1996","unstructured":"Bauersachs, J. et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94, 3341\u20133347 (1996).","journal-title":"Circulation"},{"key":"991_CR173","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02931069","volume":"12","author":"J Min","year":"2007","unstructured":"Min, J. 17\u03b2-Estradiol-stimulated eNOS gene transcriptional activation is regulated through the estrogen-responsive element in eNOS promoter. Biotechnol. Bioprocess. Eng. 12, 446\u2013449 (2007).","journal-title":"Biotechnol. Bioprocess. Eng."},{"key":"991_CR174","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bph.12315","volume":"170","author":"L Zhang","year":"2013","unstructured":"Zhang, L., Papadopoulos, P. & Hamel, E. Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer\u2019s disease. Br. J. Pharmacol. 170, 661\u2013670 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"991_CR175","doi-asserted-by":"crossref","first-page":"H1390","DOI":"10.1152\/ajpheart.01006.2006","volume":"292","author":"SP Marrelli","year":"2007","unstructured":"Marrelli, S. P., O\u2019Neil, R. G., Brown, R. C. & Bryan, R. M. PLA 2 and TRPV4 channels regulate endothelial calcium in cerebral arteries. Am. J. Physiol. Circ. Physiol. 292, H1390\u2013H1397 (2007).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"991_CR176","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0271678X15616138","volume":"36","author":"TA Longden","year":"2016","unstructured":"Longden, T. A., Hill-Eubanks, D. C. & Nelson, M. T. Ion channel networks in the control of cerebral blood flow. J. Cereb. Blood Flow Metab. 36, 492\u2013512 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"991_CR177","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.ircmb.2021.01.001","volume":"362","author":"R Stoica","year":"2021","unstructured":"Stoica, R. et al. Ca2+ homeostasis in brain microvascular endothelial cells. Int. Rev. Cell Mol. Biol. 362, 55\u2013110 (2021).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"991_CR178","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7824953","volume":"267","author":"RC Gur","year":"1995","unstructured":"Gur, R. C. et al. Sex differences in regional cerebral glucose metabolism during a resting state. Science 267, 528\u2013531 (1995).","journal-title":"Science"},{"key":"991_CR179","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4103\/1673-5374.335154","volume":"17","author":"T Lerskiatiphanich","year":"2022","unstructured":"Lerskiatiphanich, T., Marallag, J. & Lee, J. Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet. Neural Regen. Res. 17, 1975 (2022).","journal-title":"Neural Regen. Res."},{"key":"991_CR180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","volume":"11","author":"TW Tefera","year":"2021","unstructured":"Tefera, T. W., Steyn, F. J., Ngo, S. T. & Borges, K. CNS glucose metabolism in amyotrophic lateral sclerosis: a therapeutic target? Cell Biosci. 11, 14 (2021).","journal-title":"Cell Biosci."},{"key":"991_CR181","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/BST20200611","volume":"49","author":"AM Clyne","year":"2021","unstructured":"Clyne, A. M. Endothelial response to glucose: dysfunction, metabolism, and transport. Biochem. Soc. Trans. 49, 313\u2013325 (2021).","journal-title":"Biochem. Soc. Trans."},{"key":"991_CR182","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-12-820107-7.00020-3","volume":"180","author":"RM Ahmed","year":"2021","unstructured":"Ahmed, R. M., Steyn, F. & Dupuis, L. Hypothalamus and weight loss in amyotrophic lateral sclerosis. Handb. Clin. Neurol. 180, 327\u2013338 (2021).","journal-title":"Handb. Clin. Neurol."},{"key":"991_CR183","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-510X(02)00112-0","volume":"199","author":"T Kawachi","year":"2002","unstructured":"Kawachi, T. et al. Gender differences in cerebral glucose metabolism: a PET study. J. Neurol. Sci. 199, 79\u201383 (2002).","journal-title":"J. Neurol. Sci."},{"key":"991_CR184","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/biom12091228","volume":"12","author":"E Mukai","year":"2022","unstructured":"Mukai, E., Fujimoto, S. & Inagaki, N. Role of reactive oxygen species in glucose metabolism disorder in diabetic pancreatic \u03b2-cells. Biomolecules 12, 1228 (2022).","journal-title":"Biomolecules"},{"key":"991_CR185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/CS20160485","volume":"131","author":"R Ventura-Clapier","year":"2017","unstructured":"Ventura-Clapier, R. et al. Mitochondria: a central target for sex differences in pathologies. Clin. Sci. 131, 803\u2013822 (2017).","journal-title":"Clin. Sci."},{"key":"991_CR186","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-015-0271-6","volume":"4","author":"D Cacabelos","year":"2016","unstructured":"Cacabelos, D. et al. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS. Acta Neuropathol. Commun. 4, 3 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"991_CR187","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1471-4159.2006.03619.x","volume":"96","author":"M Damiano","year":"2006","unstructured":"Damiano, M. et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu\/Zn-superoxide dismutase mutant mice. J. Neurochem. 96, 1349\u20131361 (2006).","journal-title":"J. Neurochem."},{"key":"991_CR188","doi-asserted-by":"crossref","first-page":"E8316","DOI":"10.1073\/pnas.1605210113","volume":"113","author":"M Lalancette-Hebert","year":"2016","unstructured":"Lalancette-Hebert, M., Sharma, A., Lyashchenko, A. K. & Shneider, N. A. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc. Natl Acad. Sci. USA 113, E8316\u2013E8325 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR189","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2023.01.007","volume":"111","author":"A Yadav","year":"2023","unstructured":"Yadav, A. et al. A cellular taxonomy of the adult human spinal cord. Neuron 111, 328\u2013344.e7 (2023).","journal-title":"Neuron"},{"key":"991_CR190","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3390\/ijms25115633","volume":"25","author":"CS Pontifex","year":"2024","unstructured":"Pontifex, C. S., Zaman, M., Fanganiello, R. D., Shutt, T. E. & Pfeffer, G. Valosin-containing protein (VCP): a review of its diverse molecular functions and clinical phenotypes. Int. J. Mol. Sci. 25, 5633 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"991_CR191","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1139\/apnm-2020-0953","volume":"46","author":"JG Inglis","year":"2021","unstructured":"Inglis, J. G. & Gabriel, D. A. Sex differences in the modulation of the motor unit discharge rate leads to reduced force steadiness. Appl. Physiol. Nutr. Metab. 46, 1065\u20131072 (2021).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"991_CR192","doi-asserted-by":"crossref","first-page":"102675","DOI":"10.1016\/j.jelekin.2022.102675","volume":"65","author":"CA Taylor","year":"2022","unstructured":"Taylor, C. A., Kopicko, B. H., Negro, F. & Thompson, C. K. Sex differences in the detection of motor unit action potentials identified using high-density surface electromyography. J. Electromyogr. Kinesiol. 65, 102675 (2022).","journal-title":"J. Electromyogr. Kinesiol."},{"key":"991_CR193","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-3806(92)90208-E","volume":"70","author":"RB Fishman","year":"1992","unstructured":"Fishman, R. B. & Breedlove, S. M. Local perineal implants of anti-androgen block masculinization of the spinal nucleus of the bulbocavernosus. Brain Res. Dev. Brain Res. 70, 283\u2013286 (1992).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"991_CR194","unstructured":"Omar, A., Marwaha, K. & Bollu, P. C. Physiology, Neuromuscular Junction (StatPearls, 2024)."},{"key":"991_CR195","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","volume":"59","author":"S Verma","year":"2022","unstructured":"Verma, S. et al. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol. Neurobiol. 59, 1502\u20131527 (2022).","journal-title":"Mol. Neurobiol."},{"key":"991_CR196","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/(SICI)1097-4598(199911)22:11<1571::AID-MUS13>3.0.CO;2-0","volume":"22","author":"C Armon","year":"1999","unstructured":"Armon, C. & Brandstater, M. E. Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve 22, 1571\u20131575 (1999).","journal-title":"Muscle Nerve"},{"key":"991_CR197","doi-asserted-by":"publisher","unstructured":"Martineau, \u00c9., Di Polo, A., Vande Velde, C. & Robitaille, R. Sex-specific differences in motor-unit remodeling in a mouse model of ALS. eNeuro 7, https:\/\/doi.org\/10.1523\/ENEURO.0388-19.2020 (2020).","DOI":"10.1523\/ENEURO.0388-19.2020"},{"key":"991_CR198","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/brain\/awad202","volume":"146","author":"JM Shefner","year":"2023","unstructured":"Shefner, J. M. et al. Skeletal muscle in amyotrophic lateral sclerosis. Brain 146, 4425\u20134436 (2023).","journal-title":"Brain"},{"key":"991_CR199","doi-asserted-by":"crossref","first-page":"121752","DOI":"10.1016\/j.biomaterials.2022.121752","volume":"289","author":"A Badu-Mensah","year":"2022","unstructured":"Badu-Mensah, A., Guo, X., Nimbalkar, S., Cai, Y. & Hickman, J. J. ALS mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function. Biomaterials 289, 121752 (2022).","journal-title":"Biomaterials"},{"key":"991_CR200","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1089\/ars.2017.7054","volume":"28","author":"G Dobrowolny","year":"2018","unstructured":"Dobrowolny, G. et al. Muscle expression of SOD1G93A triggers the dismantlement of neuromuscular junction via PKC-theta. Antioxid. Redox Signal. 28, 1105\u20131119 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"991_CR201","doi-asserted-by":"crossref","first-page":"fcaa154","DOI":"10.1093\/braincomms\/fcaa154","volume":"2","author":"FJ Steyn","year":"2020","unstructured":"Steyn, F. J. et al. Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis. Brain Commun. 2, fcaa154 (2020).","journal-title":"Brain Commun."},{"key":"991_CR202","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","volume":"7","author":"L Palamiuc","year":"2015","unstructured":"Palamiuc, L. et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 7, 526\u2013546 (2015).","journal-title":"EMBO Mol. Med."},{"key":"991_CR203","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1152\/physiol.00024.2014","volume":"30","author":"KM Haizlip","year":"2015","unstructured":"Haizlip, K. M., Harrison, B. C. & Leinwand, L. A. Sex-based differences in skeletal muscle kinetics and fiber-type composition. Physiology 30, 30\u201339 (2015).","journal-title":"Physiology"},{"key":"991_CR204","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00421-010-1545-0","volume":"110","author":"T van Wessel","year":"2010","unstructured":"van Wessel, T., de Haan, A., van der Laarse, W. J. & Jaspers, R. T. The muscle fiber type\u2013fiber size paradox: hypertrophy or oxidative metabolism? Eur. J. Appl. Physiol. 110, 665\u2013694 (2010).","journal-title":"Eur. J. Appl. Physiol."},{"key":"991_CR205","doi-asserted-by":"crossref","first-page":"C844","DOI":"10.1152\/ajpcell.00402.2005","volume":"290","author":"EJ Anderson","year":"2006","unstructured":"Anderson, E. J. & Neufer, P. D. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H2O2 generation. Am. J. Physiol. Cell Physiol. 290, C844\u2013C851 (2006).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"991_CR206","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2017.07.008","volume":"380","author":"V Pegoraro","year":"2017","unstructured":"Pegoraro, V., Merico, A. & Angelini, C. Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J. Neurol. Sci. 380, 58\u201363 (2017).","journal-title":"J. Neurol. Sci."},{"key":"991_CR207","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1007\/s12035-023-03520-7","volume":"60","author":"BC Gomes","year":"2023","unstructured":"Gomes, B. C. et al. Differential expression of miRNAs in amyotrophic lateral sclerosis patients. Mol. Neurobiol. 60, 7104\u20137117 (2023).","journal-title":"Mol. Neurobiol."},{"key":"991_CR208","first-page":"801","volume":"17","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., Jin, A. & Yan, D. MicroRNA-206 contributes to the progression of steroid-induced avascular necrosis of the femoral head by inducing osteoblast apoptosis by suppressing programmed cell death 4. Mol. Med. Rep. 17, 801\u2013808 (2018).","journal-title":"Mol. Med. Rep."},{"key":"991_CR209","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/cells10082043","volume":"10","author":"I Casola","year":"2021","unstructured":"Casola, I. et al. Circulating myomiRs in muscle denervation: from surgical to ALS pathological condition. Cells 10, 2043 (2021).","journal-title":"Cells"},{"key":"991_CR210","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00415-018-8787-x","volume":"265","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak, A. et al. In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J. Neurol. 265, 949\u2013953 (2018).","journal-title":"J. Neurol."},{"key":"991_CR211","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0140-6736(96)90737-0","volume":"347","author":"G Kolde","year":"1996","unstructured":"Kolde, G., Bachus, R. & Ludolph, A. Skin involvement in amyotrophic lateral sclerosis. Lancet 347, 1226\u20131227 (1996).","journal-title":"Lancet"},{"key":"991_CR212","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/NEN.0b013e3182a7f0b8","volume":"72","author":"AF Buckley","year":"2013","unstructured":"Buckley, A. F. & Bossen, E. H. Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J. Neuropathol. Exp. Neurol. 72, 906\u2013918 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"991_CR213","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40478-020-00968-9","volume":"8","author":"J Saul","year":"2020","unstructured":"Saul, J. et al. Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 8, 92 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"991_CR214","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola, C. The pathobiology of vascular dementia. Neuron 80, 844\u2013866 (2013).","journal-title":"Neuron"},{"key":"991_CR215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 5, 347\u2013360 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"991_CR216","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"991_CR217","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fneur.2017.00479","volume":"8","author":"A Rosenbohm","year":"2017","unstructured":"Rosenbohm, A. et al. Cardiac findings in amyotrophic lateral sclerosis: a magnetic resonance imaging study. Front. Neurol. 8, 479 (2017).","journal-title":"Front. Neurol."},{"key":"991_CR218","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2021.12.021","volume":"96","author":"K Xu","year":"2022","unstructured":"Xu, K., Ji, H. & Hu, N. Cardiovascular comorbidities in amyotrophic lateral sclerosis: a systematic review. J. Clin. Neurosci. 96, 43\u201349 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"991_CR219","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1007\/s10072-022-06131-7","volume":"43","author":"N Hu","year":"2022","unstructured":"Hu, N. & Ji, H. Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol. Sci. 43, 5189\u20135199 (2022).","journal-title":"Neurol. Sci."},{"key":"991_CR220","doi-asserted-by":"crossref","first-page":"831179","DOI":"10.3389\/fphys.2022.831179","volume":"13","author":"SR St. Pierre","year":"2022","unstructured":"St. Pierre, S. R., Peirlinck, M. & Kuhl, E. Sex matters: a comprehensive comparison of female and male hearts. Front. Physiol. 13, 831179 (2022).","journal-title":"Front. Physiol."},{"key":"991_CR221","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.7089587","volume":"217","author":"RC Gur","year":"1982","unstructured":"Gur, R. C. et al. Sex and handedness differences in cerebral blood flow during rest and cognitive activity. Science 217, 659\u2013661 (1982).","journal-title":"Science"},{"key":"991_CR222","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/jcbfm.1988.133","volume":"8","author":"G Rodriguez","year":"1988","unstructured":"Rodriguez, G., Warkentin, S., Risberg, J. & Rosadini, G. Sex differences in regional cerebral blood flow. J. Cereb. Blood Flow Metab. 8, 783\u2013789 (1988).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"991_CR223","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1073\/pnas.1400178111","volume":"111","author":"TD Satterthwaite","year":"2014","unstructured":"Satterthwaite, T. D. et al. Impact of puberty on the evolution of cerebral perfusion during adolescence. Proc. Natl Acad. Sci. USA 111, 8643\u20138648 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"991_CR224","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1542\/peds.2006-2110","volume":"119","author":"N Tontisirin","year":"2007","unstructured":"Tontisirin, N. et al. Early childhood gender differences in anterior and posterior cerebral blood flow velocity and autoregulation. Pediatrics 119, e610\u2013e615 (2007).","journal-title":"Pediatrics"},{"key":"991_CR225","doi-asserted-by":"crossref","unstructured":"Monteiro, J. N. in Essentials of Neuroanesthesia (ed. Prabhakar, H.) 815\u2013825 (Elsevier, 2017).","DOI":"10.1016\/B978-0-12-805299-0.00049-X"},{"key":"991_CR226","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/STROKEAHA.110.605618","volume":"42","author":"BM Deegan","year":"2011","unstructured":"Deegan, B. M. et al. Elderly women regulate brain blood flow better than men do. Stroke 42, 1988\u20131993 (2011).","journal-title":"Stroke"},{"key":"991_CR227","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1203\/01.PDR.0000179405.30737.0F","volume":"58","author":"MS Vavilala","year":"2005","unstructured":"Vavilala, M. S. et al. Gender differences in cerebral blood flow velocity and autoregulation between the anterior and posterior circulations in healthy children. Pediatr. Res. 58, 574\u2013578 (2005).","journal-title":"Pediatr. Res."},{"key":"991_CR228","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells12060957","volume":"12","author":"S Schreiber","year":"2023","unstructured":"Schreiber, S. et al. Brain vascular health in ALS is mediated through motor cortex microvascular integrity. Cells 12, 957 (2023).","journal-title":"Cells"},{"key":"991_CR229","volume":"11","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. Difference in leukocyte composition between women before and after menopausal age, and distinct sexual dimorphism. PLoS ONE 11, e0162953 (2016).","journal-title":"PLoS ONE"},{"key":"991_CR230","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000953","volume":"8","author":"BJ Murdock","year":"2021","unstructured":"Murdock, B. J., Goutman, S. A., Boss, J., Kim, S. & Feldman, E. L. Amyotrophic lateral sclerosis survival associates with neutrophils in a sex-specific manner. Neurol. Neuroimmunol. Neuroinflamm. 8, e953 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"991_CR231","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jaci.2020.02.038","volume":"145","author":"HK Lehman","year":"2020","unstructured":"Lehman, H. K. & Segal, B. H. The role of neutrophils in host defense and disease. J. Allergy Clin. Immunol. 145, 1535\u20131544 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"991_CR232","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1286-4579(01)01477-0","volume":"3","author":"CA Janeway","year":"2001","unstructured":"Janeway, C. A. How the immune system protects the host from infection. Microbes Infect. 3, 1167\u20131171 (2001).","journal-title":"Microbes Infect."},{"key":"991_CR233","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.celrep.2019.10.019","volume":"29","author":"E Bongen","year":"2019","unstructured":"Bongen, E. et al. Sex differences in the blood transcriptome identify robust changes in immune cell proportions with aging and influenza infection. Cell Rep. 29, 1961\u20131973.e4 (2019).","journal-title":"Cell Rep."},{"key":"991_CR234","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2174\/156652409789839116","volume":"9","author":"P McCombe","year":"2009","unstructured":"McCombe, P., Greer, J. & Mackay, I. Sexual dimorphism in autoimmune disease. Curr. Mol. Med. 9, 1058\u20131079 (2009).","journal-title":"Curr. Mol. Med."},{"key":"991_CR235","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.3390\/ijms22137150","volume":"22","author":"JA Santiago","year":"2021","unstructured":"Santiago, J. A., Quinn, J. P. & Potashkin, J. A. Network analysis identifies sex-specific gene expression changes in blood of amyotrophic lateral sclerosis patients. Int. J. Mol. Sci. 22, 7150 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"991_CR236","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89530","volume":"2","author":"DR Beers","year":"2017","unstructured":"Beers, D. R. et al. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight 2, e89530 (2017).","journal-title":"JCI Insight"},{"key":"991_CR237","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers, D. R. & Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 18, 211\u2013220 (2019).","journal-title":"Lancet Neurol."},{"key":"991_CR238","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","volume":"48","author":"W Zhao","year":"2012","unstructured":"Zhao, W., Beers, D. R., Liao, B., Henkel, J. S. & Appel, S. H. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol. Dis. 48, 418\u2013428 (2012).","journal-title":"Neurobiol. Dis."},{"key":"991_CR239","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/STROKEAHA.121.037537","volume":"53","author":"L Beckmann","year":"2022","unstructured":"Beckmann, L. et al. Regulatory T cells contribute to sexual dimorphism in neonatal hypoxic-ischemic brain injury. Stroke 53, 381\u2013390 (2022).","journal-title":"Stroke"},{"key":"991_CR240","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03241784 (2018)."},{"key":"991_CR241","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04055623 (2021)."},{"key":"991_CR242","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01885-3","volume":"19","author":"SL Boddy","year":"2021","unstructured":"Boddy, S. L. et al. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med. 19, 13 (2021).","journal-title":"BMC Med."},{"key":"991_CR243","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/joim.13336","volume":"290","author":"J Sun","year":"2021","unstructured":"Sun, J., Huang, T., Debelius, J. W. & Fang, F. Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence. J. Intern. Med. 290, 758\u2013788 (2021).","journal-title":"J. Intern. Med."},{"key":"991_CR244","unstructured":"Mercedes Prudencio. The effects of ALS on the digestive system. Target ALS https:\/\/www.targetals.org\/2022\/08\/25\/the-effects-of-als-on-the-digestive-system\/ (2015)."},{"key":"991_CR245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/146608299300079484","volume":"1","author":"C Toepfer","year":"2000","unstructured":"Toepfer, C., Folwaczny, A., Klauser & RL, M. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, 15\u201319 (2000).","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"991_CR246","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5534\/wjmh.190009","volume":"38","author":"YS Kim","year":"2020","unstructured":"Kim, Y. S., Unno, T., Kim, B. Y. & Park, M. S. Sex differences in gut microbiota. World J. Mens Health 38, 48 (2020).","journal-title":"World J. Mens Health"},{"key":"991_CR247","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nm.4185","volume":"22","author":"BO Schroeder","year":"2016","unstructured":"Schroeder, B. O. & B\u00e4ckhed, F. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. 22, 1079\u20131089 (2016).","journal-title":"Nat. Med."},{"key":"991_CR248","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","volume":"6","author":"CR Martin","year":"2018","unstructured":"Martin, C. R., Osadchiy, V., Kalani, A. & Mayer, E. A. The brain-gut-microbiome axis. Cell. Mol. Gastroenterol. Hepatol. 6, 133\u2013148 (2018).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"991_CR249","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","volume":"535","author":"CA Thaiss","year":"2016","unstructured":"Thaiss, C. A., Zmora, N., Levy, M. & Elinav, E. The microbiome and innate immunity. Nature 535, 65\u201374 (2016).","journal-title":"Nature"},{"key":"991_CR250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/cells12050793","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang, J., Zhu, N., Su, X., Gao, Y. & Yang, R. Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells 12, 793 (2023).","journal-title":"Cells"},{"key":"991_CR251","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013 (2019).","journal-title":"Physiol. Rev."},{"key":"991_CR252","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2018.05.008","volume":"92","author":"L Rizzetto","year":"2018","unstructured":"Rizzetto, L., Fava, F., Tuohy, K. M. & Selmi, C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J. Autoimmun. 92, 12\u201334 (2018).","journal-title":"J. Autoimmun."},{"key":"991_CR253","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh, J. S. et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct. Target. Ther. 9, 37 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"991_CR254","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41575-023-00890-0","volume":"21","author":"MR Aburto","year":"2024","unstructured":"Aburto, M. R. & Cryan, J. F. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis. Nat. Rev. Gastroenterol. Hepatol. 21, 222\u2013247 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"991_CR255","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/MCG.0000000000001042","volume":"52","author":"L Mazzini","year":"2018","unstructured":"Mazzini, L. et al. Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies. J. Clin. Gastroenterol. 52, S68\u2013S70 (2018).","journal-title":"J. Clin. Gastroenterol."},{"key":"991_CR256","volume":"22","author":"HS Kim","year":"2022","unstructured":"Kim, H. S. et al. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurol. 22, 62 (2022).","journal-title":"BMC Neurol."},{"key":"991_CR257","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13443","volume":"5","author":"J Rowin","year":"2017","unstructured":"Rowin, J., Xia, Y., Jung, B. & Sun, J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol. Rep. 5, e13443 (2017).","journal-title":"Physiol. Rep."},{"key":"991_CR258","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher, E. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572, 474\u2013480 (2019).","journal-title":"Nature"},{"key":"991_CR259","volume":"3","author":"S Wu","year":"2015","unstructured":"Wu, S., Yi, J., Zhang, Y., Zhou, J. & Sun, J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 3, e12356 (2015).","journal-title":"Physiol. Rep."},{"key":"991_CR260","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","volume":"39","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin. Ther. 39, 322\u2013336 (2017).","journal-title":"Clin. Ther."},{"key":"991_CR261","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2013.10.013","volume":"1584","author":"T Hatzipetros","year":"2014","unstructured":"Hatzipetros, T. et al. C57BL\/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 1584, 59\u201372 (2014).","journal-title":"Brain Res."},{"key":"991_CR262","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awad306","volume":"147","author":"K Guo","year":"2023","unstructured":"Guo, K. et al. Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis. Brain 147, 665\u2013679 (2023).","journal-title":"Brain"},{"key":"991_CR263","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000095550","volume":"27","author":"RA Popat","year":"2006","unstructured":"Popat, R. A. et al. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology 27, 117\u2013121 (2006).","journal-title":"Neuroepidemiology"},{"key":"991_CR264","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2007.10.024","volume":"268","author":"CI Choi","year":"2008","unstructured":"Choi, C. I. et al. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J. Neurol. Sci. 268, 40\u201347 (2008).","journal-title":"J. Neurol. Sci."},{"key":"991_CR265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0034-1371891","volume":"46","author":"G Gargiulo-Monachelli","year":"2014","unstructured":"Gargiulo-Monachelli, G. et al. Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: possible markers of susceptibility and outcome. Horm. Metab. Res. 46, 433\u2013439 (2014).","journal-title":"Horm. Metab. Res."},{"key":"991_CR266","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(01)00688-8","volume":"195","author":"A Militello","year":"2002","unstructured":"Militello, A. et al. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J. Neurol. Sci. 195, 67\u201370 (2002).","journal-title":"J. Neurol. Sci."},{"key":"991_CR267","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/brain\/aws208","volume":"135","author":"HJ Kim","year":"2012","unstructured":"Kim, H. J., Magran\u00e8, J., Starkov, A. A. & Manfredi, G. The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis. Brain 135, 2865\u20132874 (2012).","journal-title":"Brain"},{"key":"991_CR268","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2004.06.024","volume":"1021","author":"GJ Groeneveld","year":"2004","unstructured":"Groeneveld, G. J. et al. Ovariectomy and 17\u03b2-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 1021, 128\u2013131 (2004).","journal-title":"Brain Res."},{"key":"991_CR269","volume":"7","author":"YE Yoo","year":"2012","unstructured":"Yoo, Y. E. & Ko, C. P. Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS ONE 7, e37258 (2012).","journal-title":"PLoS ONE"},{"key":"991_CR270","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/bph.14657","volume":"176","author":"VM McLeod","year":"2019","unstructured":"McLeod, V. M. et al. Androgen receptor antagonism accelerates disease onset in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Br. J. Pharmacol. 176, 2111\u20132130 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"991_CR271","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.neurobiolaging.2014.02.004","volume":"35","author":"T Aggarwal","year":"2014","unstructured":"Aggarwal, T. et al. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis. Neurobiol. Aging 35, 1929\u20131938 (2014).","journal-title":"Neurobiol. Aging"},{"key":"991_CR272","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/mcne.2002.1194","volume":"21","author":"K Brannvall","year":"2002","unstructured":"Brannvall, K. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell. Neurosci. 21, 512\u2013520 (2002).","journal-title":"Mol. Cell. Neurosci."},{"key":"991_CR273","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tem.2008.07.004","volume":"19","author":"I Charalampopoulos","year":"2008","unstructured":"Charalampopoulos, I., Remboutsika, E., Margioris, A. N. & Gravanis, A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab. 19, 300\u2013307 (2008).","journal-title":"Trends Endocrinol. Metab."},{"key":"991_CR274","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/glia.20404","volume":"54","author":"LM Garcia-Segura","year":"2006","unstructured":"Garcia-Segura, L. M. & Melcangi, R. C. Steroids and glial cell function. Glia 54, 485\u2013498 (2006).","journal-title":"Glia"},{"key":"991_CR275","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.psyneuen.2007.03.001","volume":"32","author":"LM Garcia-Segura","year":"2007","unstructured":"Garcia-Segura, L. M., Diz-Chaves, Y., Perez-Martin, M. & Darnaud\u00e9ry, M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology 32, S57\u2013S61 (2007).","journal-title":"Psychoneuroendocrinology"},{"key":"991_CR276","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.steroids.2007.02.003","volume":"72","author":"DW Brann","year":"2007","unstructured":"Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B. & Khan, M. M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72, 381\u2013405 (2007).","journal-title":"Steroids"},{"key":"991_CR277","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/ars.2006.8.2047","volume":"8","author":"AM Barron","year":"2006","unstructured":"Barron, A. M., Fuller, S. J., Verdile, G. & Martins, R. N. Reproductive hormones modulate oxidative stress in Alzheimer\u2019s disease. Antioxid. Redox Signal. 8, 2047\u20132059 (2006).","journal-title":"Antioxid. Redox Signal."},{"key":"991_CR278","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.01.006","volume":"114","author":"L Prokai","year":"2007","unstructured":"Prokai, L. & Simpkins, J. W. Structure\u2013nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol. Ther. 114, 1\u201312 (2007).","journal-title":"Pharmacol. Ther."},{"key":"991_CR279","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/ATVBAHA.111.228304","volume":"31","author":"M Gayard","year":"2011","unstructured":"Gayard, M. et al. AMPK alpha 1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol. Arterioscler. Thromb. Vasc. Biol. 31, 2634\u20132642 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"991_CR280","doi-asserted-by":"crossref","first-page":"5021694","DOI":"10.1155\/2020\/5021694","volume":"2020","author":"T Cunha-Oliveira","year":"2020","unstructured":"Cunha-Oliveira, T. et al. Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid. Med. Cell. Longev. 2020, 5021694 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"991_CR281","doi-asserted-by":"crossref","first-page":"2537698","DOI":"10.1155\/2019\/2537698","volume":"2019","author":"N Kakaroubas","year":"2019","unstructured":"Kakaroubas, N., Brennan, S., Keon, M. & Saksena, N. K. Pathomechanisms of blood-brain barrier disruption in ALS. Neurosci. J. 2019, 2537698 (2019).","journal-title":"Neurosci. J."},{"key":"991_CR282","doi-asserted-by":"crossref","first-page":"678","DOI":"10.12659\/MSM.908786","volume":"24","author":"L Yan","year":"2018","unstructured":"Yan, L. et al. Effects of ovariectomy in an hSOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS). Med. Sci. Monit. 24, 678\u2013686 (2018).","journal-title":"Med. Sci. Monit."},{"key":"991_CR283","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton, R. D., Yao, J., Yin, F., Mack, W. J. & Cadenas, E. Perimenopause as a neurological transition state. Nat. Rev. Endocrinol. 11, 393\u2013405 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"991_CR284","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2016.02.011","volume":"42","author":"L Zhao","year":"2016","unstructured":"Zhao, L., Mao, Z., Woody, S. K. & Brinton, R. D. Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer\u2019s disease. Neurobiol. Aging 42, 69\u201379 (2016).","journal-title":"Neurobiol. Aging"},{"key":"991_CR285","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1471-4159.2001.00345.x","volume":"77","author":"J Hammond","year":"2001","unstructured":"Hammond, J. et al. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77, 1319\u20131326 (2001).","journal-title":"J. Neurochem."},{"key":"991_CR286","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/cne.23066","volume":"520","author":"JS Byers","year":"2012","unstructured":"Byers, J. S. et al. Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury. J. Comp. Neurol. 520, 2683\u20132696 (2012).","journal-title":"J. Comp. Neurol."},{"key":"991_CR287","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1210\/en.2013-1129","volume":"154","author":"DK Hamson","year":"2013","unstructured":"Hamson, D. K. et al. Androgens increase survival of adult-born neurons in the dentate gyrus by an androgen receptor-dependent mechanism in male rats. Endocrinology 154, 3294\u20133304 (2013).","journal-title":"Endocrinology"},{"key":"991_CR288","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/17482968.2012.654393","volume":"13","author":"A Hayes-Punzo","year":"2012","unstructured":"Hayes-Punzo, A. et al. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 13, 311\u2013314 (2012).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR289","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","volume":"23","author":"E Baulieu","year":"1998","unstructured":"Baulieu, E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23, 963\u2013987 (1998).","journal-title":"Psychoneuroendocrinology"},{"key":"991_CR290","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.3390\/ijms22094889","volume":"22","author":"R Lyraki","year":"2021","unstructured":"Lyraki, R. & Schedl, A. The sexually dimorphic adrenal cortex: implications for adrenal disease. Int. J. Mol. Sci. 22, 4889 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"991_CR291","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"991_CR292","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s004150170069","volume":"248","author":"H Ishihara","year":"2001","unstructured":"Ishihara, H., Kanda, F., Nishio, H., Sumino, K. & Chihara, K. Clinical features and skewed X-chromosome inactivation in female carriers of X-linked recessive spinal and bulbar muscular atrophy. J. Neurol. 248, 856\u2013860 (2001).","journal-title":"J. Neurol."},{"key":"991_CR293","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0960-8966(99)00132-7","volume":"10","author":"C Mariotti","year":"2000","unstructured":"Mariotti, C. et al. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul. Disord. 10, 391\u2013397 (2000).","journal-title":"Neuromuscul. Disord."},{"key":"991_CR294","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt, B. J., Greenberg, C. R., Allingham-Hawkins, D. J. & Spriggs, E. L. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59, 770\u2013772 (2002).","journal-title":"Neurology"},{"key":"991_CR295","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00415-019-09251-x","volume":"266","author":"A Hashizume","year":"2019","unstructured":"Hashizume, A. et al. Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials. J. Neurol. 266, 1211\u20131221 (2019).","journal-title":"J. Neurol."},{"key":"991_CR296","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.psyneuen.2006.02.003","volume":"31","author":"M Uhart","year":"2006","unstructured":"Uhart, M., Chong, R., Oswald, L., Lin, P. & Wand, G. Gender differences in hypothalamic\u2013pituitary\u2013adrenal (HPA) axis reactivity. Psychoneuroendocrinology 31, 642\u2013652 (2006).","journal-title":"Psychoneuroendocrinology"},{"key":"991_CR297","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41386-018-0167-9","volume":"44","author":"AL Heck","year":"2019","unstructured":"Heck, A. L. & Handa, R. J. Sex differences in the hypothalamic\u2013pituitary\u2013adrenal axis\u2019 response to stress: an important role for gonadal hormones. Neuropsychopharmacology 44, 45\u201358 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"991_CR298","doi-asserted-by":"crossref","first-page":"RC23","DOI":"10.1007\/BF03349149","volume":"26","author":"FR Patacchioli","year":"2003","unstructured":"Patacchioli, F. R. et al. Adrenal dysregulation in amyotrophic lateral sclerosis. J. Endocrinol. Invest. 26, RC23\u2013RC25 (2003).","journal-title":"J. Endocrinol. Invest."},{"key":"991_CR299","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","volume":"90","author":"E Feneberg","year":"2018","unstructured":"Feneberg, E. et al. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology 90, e22\u2013e30 (2018).","journal-title":"Neurology"},{"key":"991_CR300","volume":"13","author":"T Skillb\u00e4ck","year":"2021","unstructured":"Skillb\u00e4ck, T. et al. Sex differences in CSF biomarkers for neurodegeneration and blood-brain barrier integrity. Alzheimers Dement. 13, e12141 (2021).","journal-title":"Alzheimers Dement."},{"key":"991_CR301","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani, A. et al. Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis. JAMA Neurol. 74, 525 (2017).","journal-title":"JAMA Neurol."},{"key":"991_CR302","doi-asserted-by":"crossref","first-page":"1132808","DOI":"10.3389\/fnagi.2023.1132808","volume":"15","author":"F Verde","year":"2023","unstructured":"Verde, F. et al. Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis. Front. Aging Neurosci. 15, 1132808 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"991_CR303","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12882-018-1126-8","volume":"19","author":"A Fenton","year":"2018","unstructured":"Fenton, A. et al. Glomerular filtration rate: new age- and gender-specific reference ranges and thresholds for living kidney donation. BMC Nephrol. 19, 336 (2018).","journal-title":"BMC Nephrol."},{"key":"991_CR304","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1471-4159.2009.06386.x","volume":"111","author":"K Boylan","year":"2009","unstructured":"Boylan, K. et al. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J. Neurochem. 111, 1182\u20131191 (2009).","journal-title":"J. Neurochem."},{"key":"991_CR305","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/17482960801984358","volume":"9","author":"K Frutiger","year":"2008","unstructured":"Frutiger, K., Lukas, T. J., Gorrie, G., Ajroud-Driss, S. & Siddique, T. Gender difference in levels of Cu\/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 9, 184\u2013187 (2008).","journal-title":"Amyotroph. Lateral Scler."},{"key":"991_CR306","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-022-00291-4","volume":"11","author":"A Zamani","year":"2022","unstructured":"Zamani, A. et al. Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis. Transl. Neurodegener. 11, 17 (2022).","journal-title":"Transl. Neurodegener."},{"key":"991_CR307","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neures.2020.10.006","volume":"171","author":"M Hirose","year":"2021","unstructured":"Hirose, M. et al. Stagnation of glymphatic interstitial fluid flow and delay in waste clearance in the SOD1-G93A mouse model of ALS. Neurosci. Res. 171, 74\u201382 (2021).","journal-title":"Neurosci. Res."},{"key":"991_CR308","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/brain\/awad274","volume":"147","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis. Brain 147, 100\u2013108 (2024).","journal-title":"Brain"},{"key":"991_CR309","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1074\/mcp.RA119.001343","volume":"18","author":"C Shao","year":"2019","unstructured":"Shao, C. et al. Comprehensive analysis of individual variation in the urinary proteome revealed significant gender differences. Mol. Cell. Proteom. 18, 1110\u20131122 (2019).","journal-title":"Mol. Cell. Proteom."},{"key":"991_CR310","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/imm.13634","volume":"169","author":"D Sharygin","year":"2023","unstructured":"Sharygin, D., Koniaris, L. G., Wells, C., Zimmers, T. A. & Hamidi, T. Role of CD14 in human disease. Immunology 169, 260\u2013270 (2023).","journal-title":"Immunology"},{"key":"991_CR311","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/QAD.0000000000000735","volume":"29","author":"CL Shive","year":"2015","unstructured":"Shive, C. L., Jiang, W., Anthony, D. D. & Lederman, M. M. Soluble CD14 is a nonspecific marker of monocyte activation. AIDS 29, 1263\u20131265 (2015).","journal-title":"AIDS"},{"key":"991_CR312","doi-asserted-by":"crossref","first-page":"fcad287","DOI":"10.1093\/braincomms\/fcad287","volume":"5","author":"ML Rogers","year":"2023","unstructured":"Rogers, M. L., Schultz, D. W., Karnaros, V. & Shepheard, S. R. Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations. Brain Commun. 5, fcad287 (2023).","journal-title":"Brain Commun."},{"key":"991_CR313","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","volume":"29","author":"M Bogdanov","year":"2000","unstructured":"Bogdanov, M. et al. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 29, 652\u2013658 (2000).","journal-title":"Free Radic. Biol. Med."},{"key":"991_CR314","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nmt-2020-0033","volume":"10","author":"Y Saitoh","year":"2020","unstructured":"Saitoh, Y. & Takahashi, Y. Riluzole for the treatment of amyotrophic lateral sclerosis. Neurodegener. Dis. Manag. 10, 343\u2013355 (2020).","journal-title":"Neurodegener. Dis. Manag."},{"key":"991_CR315","first-page":"1280","volume":"282","author":"CS Huang","year":"1997","unstructured":"Huang, C. S., Song, J. H., Nagata, K., Yeh, J. Z. & Narahashi, T. Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 282, 1280\u20131290 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"991_CR316","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","volume":"17","author":"T Fang","year":"2018","unstructured":"Fang, T. et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 17, 416\u2013422 (2018).","journal-title":"Lancet Neurol."},{"key":"991_CR317","first-page":"246","volume":"8","author":"L Chen","year":"2016","unstructured":"Chen, L., Liu, X., Tang, L., Zhang, N. & Fan, D. Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China. Front. Aging Neurosci. 8, 246 (2016).","journal-title":"Front. Aging Neurosci."},{"key":"991_CR318","first-page":"1465","volume":"282","author":"GJ Sanderink","year":"1997","unstructured":"Sanderink, G. J., Bournique, B., Stevens, J., Petry, M. & Martinet, M. Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J. Pharmacol. Exp. Ther. 282, 1465\u20131472 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"991_CR319","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2125.2000.00128.x","volume":"49","author":"D Ou\u2010Yang","year":"2000","unstructured":"Ou\u2010Yang, D. et al. Phenotypic polymorphism and gender\u2010related differences of CYP1A2 activity in a Chinese population. Br. J. Clin. Pharmacol. 49, 145\u2013151 (2000).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"991_CR320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/tx00022a001","volume":"4","author":"FP Guengerich","year":"1991","unstructured":"Guengerich, F. P. & Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391\u2013407 (1991).","journal-title":"Chem. Res. Toxicol."},{"key":"991_CR321","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0b013e3181c1df48","volume":"73","author":"C Armon","year":"2009","unstructured":"Armon, C. Smoking may be considered an established risk factor for sporadic ALS. Neurology 73, 1693\u20131698 (2009).","journal-title":"Neurology"},{"key":"991_CR322","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ypmed.2015.06.009","volume":"80","author":"ST Higgins","year":"2015","unstructured":"Higgins, S. T. et al. A literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004\u20132014. Prev. Med. 80, 89\u2013100 (2015).","journal-title":"Prev. Med."},{"key":"991_CR323","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0009-9236(97)90047-3","volume":"62","author":"R Bruno","year":"1997","unstructured":"Bruno, R. et al. Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis. Clin. Pharmacol. Ther. 62, 518\u2013526 (1997).","journal-title":"Clin. Pharmacol. Ther."},{"key":"991_CR324","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","volume":"387","author":"TM Miller","year":"2022","unstructured":"Miller, T. M. et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N. Engl. J. Med. 387, 1099\u20131110 (2022).","journal-title":"N. Engl. J. Med."},{"key":"991_CR325","first-page":"12","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker, P. et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J. Neurol. Neurosurg. Psychiatry 87, 12\u201320 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR326","doi-asserted-by":"crossref","first-page":"fcac029","DOI":"10.1093\/braincomms\/fcac029","volume":"4","author":"AG Thompson","year":"2022","unstructured":"Thompson, A. G. et al. Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Commun. 4, fcac029 (2022).","journal-title":"Brain Commun."},{"key":"991_CR327","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","volume":"95","author":"M Benatar","year":"2020","unstructured":"Benatar, M. et al. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95, e59\u2013e69 (2020).","journal-title":"Neurology"},{"key":"991_CR328","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00415-020-09761-z","volume":"267","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh, S. et al. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis. J. Neurol. 267, 1699\u20131708 (2020).","journal-title":"J. Neurol."},{"key":"991_CR329","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp-2019-322309","volume":"91","author":"M De Schaepdryver","year":"2020","unstructured":"De Schaepdryver, M. et al. Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 91, 436\u2013437 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR330","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu, C. H. et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84, 2247\u20132257 (2015).","journal-title":"Neurology"},{"key":"991_CR331","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","volume":"90","author":"F Verde","year":"2019","unstructured":"Verde, F. et al. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 90, 157\u2013164 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR332","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K Poesen","year":"2019","unstructured":"Poesen, K. & Van Damme, P. Diagnostic and prognostic performance of neurofilaments in ALS. Front. Neurol. 9, 1167 (2019).","journal-title":"Front. Neurol."},{"key":"991_CR333","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jnnp-2016-313521","volume":"88","author":"T Bali","year":"2017","unstructured":"Bali, T. et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J. Neurol. Neurosurg. Psychiatry 88, 99\u2013105 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"991_CR334","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13293-022-00422-6","volume":"13","author":"P Shobeiri","year":"2022","unstructured":"Shobeiri, P., Kalantari, A., Teixeira, A. L. & Rezaei, N. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biol. Sex Differ. 13, 12 (2022).","journal-title":"Biol. Sex Differ."},{"key":"991_CR335","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2022.04.012","volume":"185","author":"NS Stachenfeld","year":"2022","unstructured":"Stachenfeld, N. S. & Mazure, C. M. Precision medicine requires understanding how both sex and gender influence health. Cell 185, 1619\u20131622 (2022).","journal-title":"Cell"},{"key":"991_CR336","doi-asserted-by":"crossref","first-page":"104987","DOI":"10.1016\/j.isci.2022.104987","volume":"25","author":"T Bohr","year":"2022","unstructured":"Bohr, T. et al. The glymphatic system: current understanding and modeling. iScience 25, 104987 (2022).","journal-title":"iScience"},{"key":"991_CR337","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1523\/JNEUROSCI.0619-21.2021","volume":"41","author":"LM Hablitz","year":"2021","unstructured":"Hablitz, L. M. & Nedergaard, M. The glymphatic system: a novel component of fundamental neurobiology. J. Neurosci. 41, 7698\u20137711 (2021).","journal-title":"J. Neurosci."},{"key":"991_CR338","doi-asserted-by":"crossref","first-page":"689938","DOI":"10.3389\/fnins.2021.689938","volume":"15","author":"A Yuan","year":"2021","unstructured":"Yuan, A. & Nixon, R. A. Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front. Neurosci. 15, 689938 (2021).","journal-title":"Front. Neurosci."},{"key":"991_CR339","doi-asserted-by":"crossref","first-page":"19633","DOI":"10.1074\/jbc.272.32.19633","volume":"272","author":"KB Beckman","year":"1997","unstructured":"Beckman, K. B. & Ames, B. N. Oxidative decay of DNA. J. Biol. Chem. 272, 19633\u201319636 (1997).","journal-title":"J. Biol. Chem."},{"key":"991_CR340","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932\u2013936 (2005).","journal-title":"Nature"},{"key":"991_CR341","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbadis.2006.04.005","volume":"1762","author":"D Lambrechts","year":"2006","unstructured":"Lambrechts, D. & Carmeliet, P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim. Biophys. Acta Mol. Basis Dis. 1762, 1109\u20131121 (2006).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"991_CR342","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jmg.2008.058222","volume":"46","author":"D Lambrechts","year":"2009","unstructured":"Lambrechts, D. et al. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J. Med. Genet. 46, 840\u2013846 (2009).","journal-title":"J. Med. Genet."},{"key":"991_CR343","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jnr.24368","volume":"97","author":"Y Ohta","year":"2019","unstructured":"Ohta, Y. et al. Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis. J. Neurosci. Res. 97, 607\u2013619 (2019).","journal-title":"J. Neurosci. Res."},{"key":"991_CR344","unstructured":"Canadian Agency for Drugs and Technologies in Health. Sodium Phenylbutyrate and Ursodoxicoltaurine (Albrioza) (CADTH, 2022)."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-00991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-00991-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-00991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:09:21Z","timestamp":1722416961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-00991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":344,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1038\/s41582-024-00991-7","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"7 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}